跳至主要内容
临床试验/NCT03677024
NCT03677024撤回不适用

Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas

Fudan University1 个研究点 分布在 1 个国家开始时间: 2020年2月6日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Performance Analysis

研究概览

简要总结

To evaluate the efficacy of sentinel lymph node policy in patients with intermediate-risk endometrial carcinomas

详细描述

Surgical assessment for staging of endometrial carcinoma during primary surgery remains one of the most varied practices worldwide, as it may include no nodal assessment, sentinel node mapping, and complete pelvic and aortic lymphadenectomy up to the renal vessels. Since lymphadenectomy is significantly associated with longer operating time, higher surgical costs, greater rate of infection, as well as the occurrence of lymphocysts and lymphedema, gynecologists agree that pelvic and aortic lymphadenectomy should be routinely performed in high-risk patients (grade 3, deep myometrial invasion, type 2 cancer). However, whether lymphadenectomy is required in patients with endometrioid endometrial cancers of grade 1 or 2 and with less than 50% myometrial invasion is controversial. Then, the investigators conducted this prospective cohort study to investigate the efficacy of sentinel lymph node policy in patients with intermediate-risk endometrial carcinomas (grade 1 or 2, < 50% myometrial invasion, and a tumor diameter ≥ 2 cm) as well as their outcomes.

Surgery should be performed within a maximum of 4 weeks from the patient's first consultation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • No contraindication to surgery.
  • Signed and dated informed consent.
  • Intermediate-risk endometrioid cancer with grade 1-2, superficial myometrial invasion and tumor diameter ≥ 2cm (in intraoperative frozen section examinations).
  • Without any suspicious pelvic, paraaortic or distant lymph node metastasis in preoperative imaging tests including MRI/CT/PET-CT.

排除标准

  • Low-risk endometrioid cancer with grade 1-2, superficial myometrial invasion and tumor diameter < 2cm (in intraoperative frozen section examinations).
  • Grade 3 endometrioid cancer (in preoperative pathological diagnosis or in intraoperative frozen section examinations).
  • Deep muscular infiltration (in intraoperative frozen section examinations).
  • Cervical invasion and/or ovarian/tubal invasion (in intraoperative frozen section examinations).
  • With suspicious pelvic, paraaortic or distant lymph node metastasis in preoperative imaging tests including MRI/CT/PET-CT.

结局指标

主要结局

Performance Analysis

时间窗: Within 14 days after the surgery

Using the final pathological diagnosis as the Gold Standard, the investigators will calculate the sensitivity, specificity, and predictive accuracy of mapping and detection of SLN with metastatic disease.

次要结局

  • Adjuvant therapy rate(5 years after the surgery)
  • Postoperative complications(1 years after the surgery)
  • Recurrence rate(5 years after the surgery)
  • 5-year survival rate(5 years after the surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaojun Chen

Principal Investigator

Fudan University

研究点 (1)

Loading locations...

相似试验

Evaluation of the Efficacy for Sentinel Lymph Node... | 临床试验